Peter Rothwell

Peter Rothwell

University of Oxford

H-index: 170

Europe-United Kingdom

About Peter Rothwell

Peter Rothwell, With an exceptional h-index of 170 and a recent h-index of 99 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of TIA, stroke, hypertension, aspirin, randomised trials.

His recent articles reflect a diverse array of research interests and contributions to the field:

C-Reactive Protein, Interleukin-6, and Vascular Recurrence According to Stroke Subtype: An Individual Participant Data Meta-Analysis

Age-specific sex-differences in cerebral blood flow velocity in relation to haemoglobin levels

Plasma fibrinogen and risk of vascular recurrence after ischaemic stroke: An individual participant and summary-level data meta-analysis of 11 prospective studies

Long-Term Outcomes in Patients With Spontaneous Cerebellar Hemorrhage: An International Cohort Study

Stroke in the time of circadian medicine

Retinal imaging for the assessment of stroke risk: a systematic review

Association of multimorbidity with mortality after stroke stratified by age, severity, etiology, and prior disability

Rapid outpatient transient ischemic attack clinic and stroke service activity during the SARS-CoV-2 pandemic: a multicenter time series analysis

Peter Rothwell Information

University

Position

___

Citations(all)

205491

Citations(since 2020)

75333

Cited By

146155

hIndex(all)

170

hIndex(since 2020)

99

i10Index(all)

599

i10Index(since 2020)

439

Email

University Profile Page

Google Scholar

Peter Rothwell Skills & Research Interests

TIA

stroke

hypertension

aspirin

randomised trials

Top articles of Peter Rothwell

C-Reactive Protein, Interleukin-6, and Vascular Recurrence According to Stroke Subtype: An Individual Participant Data Meta-Analysis

Neurology

2024/1/23

Age-specific sex-differences in cerebral blood flow velocity in relation to haemoglobin levels

European Stroke Journal

2024/4/18

Plasma fibrinogen and risk of vascular recurrence after ischaemic stroke: An individual participant and summary-level data meta-analysis of 11 prospective studies

European Stroke Journal

2024/4/10

Long-Term Outcomes in Patients With Spontaneous Cerebellar Hemorrhage: An International Cohort Study

Stroke

2024/3/15

Stroke in the time of circadian medicine

2024/3/15

Retinal imaging for the assessment of stroke risk: a systematic review

2024/3/2

Association of multimorbidity with mortality after stroke stratified by age, severity, etiology, and prior disability

International Journal of Stroke

2024/3

Rapid outpatient transient ischemic attack clinic and stroke service activity during the SARS-CoV-2 pandemic: a multicenter time series analysis

Frontiers in Neurology

2024/2/7

Association Between Socioeconomic Deprivation, Stroke Incidence and Long-Term Outcome: 10-year Follow-Up From a Population-Based Cohort Study of All Strokes in Oxfordshire, UK

Stroke

2024/2

Matthew Downer
Matthew Downer

H-Index: 6

Peter Rothwell
Peter Rothwell

H-Index: 100

Abstract TP22: Delirium, Infection, and Risk of Dementia in Patients With and Without Cerebral Small Vessel Disease

Stroke

2024/2

Matthew Downer
Matthew Downer

H-Index: 6

Peter Rothwell
Peter Rothwell

H-Index: 100

Infection, delirium, and risk of dementia in patients with and without white matter disease on previous brain imaging: a population-based study

The Lancet Healthy Longevity

2024/2/1

Prevalence and outcomes of frailty in unplanned hospital admissions: a systematic review and meta-analysis of hospital-wide and general (internal) medicine cohorts

2023/5/1

Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study

The Lancet Neurology

2023/4/1

Rural versus metropolitan comparison of processes of care in the community‐based management of TIA and minor stroke in Australia (an analysis from the INSIST study)

Australian Journal of Rural Health

2023/4

Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs): a multicentre, open-label, randomised, crossover trial

The Lancet Neurology

2023/11/1

Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke

2023/4

Blood pressure variability and beta-blockers are related to stroke risk

2023/3/5

Author Response: About the pre-stroke mRS

2023/3/4

The EffecTs of Amlodipine and other Blood PREssure Lowering Agents on Microvascular FuncTion in Small Vessel Diseases (TREAT-SVDs) trial: study protocol for a randomised …

European Stroke Journal

2023/3

S-28-1: CARDIOVASCULAR OUTCOMES IN ADULTS WITH HYPERTENSION WITH EVENING VERSUS MORNING DOSING OF USUAL ANTIHYPERTENSIVES IN THE UK. THE TIME STUDY

Journal of Hypertension

2023/1/1

See List of Professors in Peter Rothwell University(University of Oxford)